ArticleCancers2020

Clinical Response to the CD95-Ligand Inhibitor Asunercept Is Defined by a Pro-Inflammatory Serum Cytokine Profile.

Aleksandar Radujkovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.